The Spanish Life Sciences Web Portal
This is a free web portal for the life sciences in Spain and Portugal... » read more
- PharmaMar Starts Pivotal Phase 3 with Lurbinectedin (PM1183) (2016-08-02)
PharmaMar (MSE:PHM) today announced the start of a pivotal Phase III ATLANTIS study evaluating efficacy and safety of PM1183 (lurbinectedin) in combination with doxorubicin versus topotecan or the combination VCR (cyclophosphamide, adriamicine (doxorubicin) and vin...
- Nicox Transfers Commercial Operations to GHO Capital (2016-07-05)
> Transaction values Nicox’s European and International commercial operations and related late-stage development programs at up to €26 million > Nicox to receive a €9 million upfront cash payment and a minority stake in the new company > Nicox to focus resour...
- Qiagen Issues $730m Convertible Notes (2016-06-21)
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with Weill Cornell Medicine in a global study seeking insights on the prevalence of pathogens, including antimicrobial resistance, in urban environments. Starting today, resea...
- Sygnis: Detection, Amplification of Cell- free DNA in Blood (2016-06-17)
> New tool is based on SYGNIS’ TruePrime technology > Enables the early detection of cancer using a blood sample instead of tissue biopsies > Several top-level collaborations with hospitals and research centers in Europe and the US established to further deve...
- Minoryx Therapeutics Appoints Uwe Meya as CMO (2016-06-14)
Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, today announces the appointment of Dr. Uwe Meya as Chief Medical Officer (CMO). As a specialist in neurological disorders, Dr. Meya will advance the c...
- Axol Bioscience: MESO-BRAIN Consortium Gets €3.3m EU Funding (2016-06-09)
The MESO-BRAIN consortium has received a prestigious award of €3.3 million in funding from the European Commission as part of its Future and Emerging Technology (FET) scheme. The project aims to develop three-dimensional (3D) human neural networks with specific bio...
- PharmaMar Starts Trading on MSE, after Reverse Merger (2015-11-02)
PharmaMar (MSE:PHM) announced today that the Company started trading on the BME Spanish stock exchange after completing the reverse merger with Zeltia. The new PharmaMar shares began trading this morning. The exchange ratio between the shares of the two companies w...
Life-Sciences-Spain.com is your doorway to the Iberian life sciences!
[LSES] provides free, up-to-date and structured access to
in Spain and Portugal.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSES] is 100% Made in Germany!Start here with the latest News!
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)